WINT•benzinga•
Windtree Announces Japanese Patent Titled Inhibitors of atypical protein kinase C (aPKCi) and their use in treating hedgehog pathway-dependent cancers. Expiring In 2040
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on January 15, 2025 by benzinga